1. Compared to standard chemotherapy alone, the addition of the rituximab significantly improves event-free survival among adults with CD20-positive, Philadelphia...

1. In patients with congestive heart failure (CHF) and reduced ejection fraction, mortality was significantly lower in patients who received...

1. Patients with noninfectious intermediate or posterior uveitis or panuveitis had their symptoms controlled for longer on adalimumab treatment compared...

1. Continuous positive airway pressure (CPAP) use did not decrease the incidence of the primary composite cardiovascular event end point....

1. Survival after allogeneic hematopoietic cell transplant was better in patients treated with cord blood than in patients treated with...

1. The rate of adverse asthma-related events was similar in patients with asthma treated with fixed-dosed salmeterol-fluticasone therapy compared to...

1. Individuals infected with HIV-1 who were randomized to receive antiretroviral therapy (ART) at trial enrollment had a 97% and...

1. For patients with moderate-to-severe asthma, budesonide-formoterol combination therapy was not associated with a higher risk of serious asthma-related events...

1. Addition of daratumumab to bortezomib and dexamethasone increased the rate and length of progression-free survival. 2. The rates of...

1. Patients undergoing MRI focused ultrasound thalamotomy had their essential tremor symptoms significantly reduced by 3-months post-procedure and maintained at...